Nasal Polyps
97
12
16
53
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
29 trials with published results (30%)
Research Maturity
53 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
6.2%
6 terminated out of 97 trials
89.8%
+3.2% vs benchmark
34%
33 trials in Phase 3/4
55%
29 of 53 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 53 completed trials
Clinical Trials (97)
Biologics in Chronic Rhinosinusitis With Nasal Polyposis
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
Triamcinolone Nanocapsules After Endoscopic Nasal Surgery
Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)
Effect of Mepolizumab in Severe Bilateral Nasal Polyps
BIOlogics in Severe Nasal POlyposis SurvEy.: a French Registry
In-clinic Endoscopic Polypectomy for Chronic Sinusitis With Nasal Polyps
Pilot Study of The EPIC Trial
Complete Remission After Treatment With Biologics for Nasal Polyps
A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps
Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps
Effect of Full-House ESS With Nasopharyngeal Lymphoid Tissue Ablation on Nasal Polyps
Role of IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP
The Effect of Modified Radical Endoscopic Sinus Surgery on Eosinopilic Chronic Rhinosinusitus With Nasal Polyps
Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-2)
Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps
A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps